HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas

Oncogene

Volumn 14, Issue 24, 1997, Pages 2935-2941

  Berner, Jeanne Marie ^a   Meza Zepeda, Leonardo A ^a   Kools, Patrick F J ^b   Forus, Anne ^a   Schoenmakers, Eric F P M ^b   Van De Ven, Wim J M ^b   Fodstad, Øystein ^a   Myklebost, Ola ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Amplicon; Chromosome 12q13 15; HMGIC; MAR; MDM2

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; CHROMOSOME 12; DNA FLANKING REGION; EXON; GENE AMPLIFICATION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; LIPOSARCOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SARCOMA;

AMINO ACID SEQUENCE; BASE SEQUENCE; BLOTTING, NORTHERN; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 12; GENE AMPLIFICATION; GENE REARRANGEMENT; HIGH MOBILITY GROUP PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; SARCOMA; TRANSCRIPTION FACTORS;

EID: 0030750766     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201135     Document Type: Article

References (35)

1. Ashar HR, Fejzo MS, Tkachenko A, Zhou X, Fletcher JA, Weremowicz S, Morton CC and Chada K. (1995). Cell, 82, 57-65.
2. Berlingieri MT, Manfioletti G, Santoro M, Bandiera A, Visconti R, Giancotti V and Fusco A. (1995). Mol. Cell. Biol., 15, 1545-1553.
3. Berner J-M, Forus A, El Kahloun A, Meltzer PS, Fodstad Ø and Myklebost O. (1996). Genes Chrom. Cancer, 17, 254-259.
4. Chiappetta G, Bandiera A, Berlingieri MT, Visconti R, Manfioletti G, Battista S, Martinez-Tello FJ, Santoro M, Giancotti V and Fusco A. (1995). Oncogene, 10, 1307-1314.
5. Dal Cin P, Kools P, Sciot R, De Wever I, Van Damme B, Van de Ven W and Van den Berghe H. (1993). Cancer Genet. Cytogenet., 68, 85-90.
6. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J and Livingston DM. (1993). Cell, 73, 487-497.
7. FlŁrenes VA, Maelandsmo GM, Forus A, Andreassen Å, Myklebost Ø and Fodstad O. (1994). JNCI, 86, 1297-1302.
8. Forus A, Maelandsmo GM, Fodstad Ø and Myklebost O. (1991). Cytogenet. Cell Genet., 58, 1977.
9. Forus A, Flørenes VA, Maelandsmo GM, Meltzer PS, Fodstad Ø and Myklebost O. (1993). Cell Growth Differ., 4, 1065-1070.
10. Forus A, Flørenes VA, Maelandsmo GM, Fodstad Ø and Myklebost O. (1994). Cancer Genet. Cytogenet., 78, 165-171.
11. Forus A, Olde Weghuis D, Smeets D, Fodstad Ø, Myklebost O and Geurts van Kessel A. (1995a). Genes Chrom. Cancer, 14, 8-14.
12. Forus A, Olde Weghuis D, Smeets D, Fodstad Ø, Myklebost O and Geurts van Kessel A. (1995b). Genes Chrom. Cancer, 14, 15-21.
13. Grosschedl R, Giese K and Pagel J. (1994). Trend Genet., 10, 94-100.
14. Huang L-S, Bock SC, Feinstein SI and Breslow JL. (1985). Proc. Natl. Acad. Sci. USA, 82, 6825-6829.
15. Kazmierczak B, Hennig Y, Wanschura S, Rogalla P, Bartnitzke S, Van de Ven W and Bullerdiek J. (1995). Cancer Res., 55, 6038-6039.
16. Kazmierczak B, Rosigkeit J, Wanschura S, Meyer-Bolte K, Van de Ven WJM, Kayser K, Krieghoff B, Kastendiek H, Bartnitzke S and Bullerdiek J. (1996). Oncogene, 12, 515-521.
17. Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ and Look AT. (1993). Cancer Res., 53, 5535-5541.
18. Kools PFJ and Van de Ven WJM. (1996). Cancer Genet. Cytogenet., 91, 1-7.
19. Maelandsmo GM, Berner J-M, Flørenes VA, Forus A, Hovig E, Fodstad Ø and Myklebost O. (1995). Br. J. Cancer, 72, 393-398.
20. Momand J, Zambetti GP, Olson DC, George D and Levine AJ. (1992). Cell, 69, 1237-1245.
21. Oliner JD, Kinzler KW, Meltzer PS, George DL and Vogelstein B. (1992). Nature, 358, 80-83.
22. Patel UA, Bandiera A, Manfioletti G, Giancotti V, Chau K-Y and Crane-Robinson C. (1994). Biochem. Biophys. Res. Commun., 201, 63-70.
23. Pedeutour F, Suijkerbuijk RF, Forus A, Van Gaal J, van de Klundert W, Coindre J-M, Nicolo G, Collin F, Van Haelst U, Huffermann K and Turc-Carel C. (1994). Genes Chrom. Cancer, 10, 85-94.
24. Reeves R and Nissen MS. (1990). J. Biol. Chem., 265, 8576-8582.
25. Roberts WM, Douglass EC, Peiper SC, Houghton PJ and Look AT. (1989). Cancer Res., 49, 5407-5413.
26. Schajowich F. (1993). Histological Typing of Bone Tumours, Second edition edn. Springer-Verlag, Berlin.
27. Schoenmakers EFPM, Kools PFJ, Mols R, Kazmierczak B, Bartnitzke S, Bullerdiek J, Dal Cin P, De Jong PJ, Van den Berghe H and Van de Ven WJM. (1994). Genomics, 20, 210-222.
28. Schoenmakers EFPM, Geurts JMW, Kools PFJ, Mols R, Huysmans C, Bullerdiek J, Van den Berghe H and Van de Ven WJM. (1995a). Genomics, 29, 665-678.
29. Schoenmakers EFPM, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H and Van de Ven WJM. (1995b). Nature Genet., 10, 436-444.
30. Smith SH, Weiss SW, Jankowski SA, Coccia MA and Meltzer PS. (1992). Cancer Res., 52, 3746-3749.
31. Van de Ven WJM, Schoenmakers EFPM, Wanschura S, Kazmierczak B, Kools PFJ, Geurts JMW, Bartnitzke S, Van den Berghe H and Bullerdiek J. (1995). Genes Chrom. Cancer, 12, 296-303.
32. Wanschura S, Kazmierczak B, Schoenmakers E, Meyen E, Bartnizke S, Van de Ven W and Bullerdiek J. (1995). Genes Chrom. Cancer, 14, 68-70.
33. Weiss SW. (1994). Histological Typing of Soft Tissue Tumours, Second edition edn, Springer-Verlag, Berlin.
34. Wollfe AP. (1994). Science, 264, 1100-1101.
35. Zhou X, Benson KF, Ashar HR and Chada K. (1995). Nature, 376, 771-774.